Posts Tagged: Paul Santerre
Professor Paul Santerre has been elected as a Fellow of the National Academy of Inventors (NAI), the highest professional distinction awarded to academic inventors. This honour recognizes individuals whose patented innovations have made a significant and lasting impact on quality of life, economic development, and the advancement of society.
Cohesys is a Toronto-based medical device startup revolutionizing how surgeons treat facial fractures. Spun out of research at the University of Toronto’s Institute of Biomedical Engineering, Cohesys was founded by alumni Alex Jucan and Michael Floros. Their flagship innovation, BoneTape, is a flexible surgical adhesive designed to replace traditional metal plates and screws in craniomaxillofacial procedures.
Discover how Professor Paul Santerre and his team at the University of Toronto are using smart biomaterials to tackle some of today’s most pressing health challenges: from cardiovascular disease and dental repair to bone healing and tissue regeneration.
From foundational work in evidence-based medicine to the cutting edge of AI in business, McMaster is recognizing nine extraordinary individuals for their accomplishments and contributions at this year’s spring convocation ceremonies.
The University of Toronto and its partners are receiving $4.25 million over the next five years to establish a national hub aimed at accelerating the commercialization of life sciences discoveries.
The Discovery Grant program is dedicated to supporting researchers as they venture into new territories to find solutions to pressing issues such as environmental protection, food security, and sustainable construction in cold climates. It aims to promote and maintain a diverse and high-quality research capability in the natural sciences and engineering at Canadian universities, foster research excellence, and provide a stimulating environment for research training.
Completed her Ph.D. in Dr. Paul Santerre’s lab in 2019, Dr. Meghan Wright always had a passion for entrepreneurship, business, and science. After graduating, Meghan interned briefly with the life sciences investment firm Bloom Burton & Co. as a consultant before joining Shift Health, a life sciences and healthcare strategy consulting firm located in Toronto. Now Meghan is working on projects across a wide range of areas – from the private sector to academia, to help transform healthcare.
In the 4th volume of Nature’s Communications Biology, researchers at TBEP published an important study that can reshape the way we engineer new blood vessels for patients who need them.
An innovative biomaterial discovery by researchers at the University of Toronto in collaboration with Ripple Therapeutics Inc., has established a method that yields better control over drug release profiles in implants and has the potential to disrupt the classical drug delivery market.
Showing 1 - 10 of 36 results